Research ArticleClinical Studies
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS and EPAMINONTAS SAMANTAS
Anticancer Research February 2020, 40 (2) 929-938; DOI: https://doi.org/10.21873/anticanres.14026
JOSEPH SGOUROS
1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
GERASIMOS ARAVANTINOS
2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
GEORGIA-ANGELIKI KOLIOU
3Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece
GEORGE PENTHEROUDAKIS
4Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece
5Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece
FLORA ZAGOURI
6Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
AMANDA PSYRRI
7Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
DIMITRA IOANNA LAMPROPOULOU
2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
STAMATINA DEMIRI
8Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece
DIMITRIOS PECTASIDES
9Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece
EVANGELIA RAZIS
10Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece
GEORGE FOUNTZILAS
11Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece
12Aristotle University of Thessaloniki, Thessaloniki, Greece
13German Oncology Center, Limassol, Cyprus
EPAMINONTAS SAMANTAS
1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Anticancer Research
Vol. 40, Issue 2
February 2020
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS, EPAMINONTAS SAMANTAS
Anticancer Research Feb 2020, 40 (2) 929-938; DOI: 10.21873/anticanres.14026
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS, EPAMINONTAS SAMANTAS
Anticancer Research Feb 2020, 40 (2) 929-938; DOI: 10.21873/anticanres.14026
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.